tiprankstipranks
Trending News
More News >
Pacific Smiles Group Ltd (AU:PSQ)
:PSQ
Australian Market
Advertisement

Pacific Smiles Group Ltd (PSQ) AI Stock Analysis

Compare
12 Followers

Top Page

AU:PSQ

Pacific Smiles Group Ltd

(Sydney:PSQ)

Select Model
Select Model
Select Model
Neutral 63 (OpenAI - 4o)
Rating:63Neutral
Price Target:
AU$2.50
▲(14.68% Upside)
The overall stock score for Pacific Smiles Group Ltd is primarily influenced by its strong technical performance, with the stock showing a robust upward trend. However, the high P/E ratio suggests overvaluation, and financial performance highlights concerns with profitability and leverage. These factors collectively moderate the overall score.

Pacific Smiles Group Ltd (PSQ) vs. iShares MSCI Australia ETF (EWA)

Pacific Smiles Group Ltd Business Overview & Revenue Model

Company DescriptionPacific Smiles Group Ltd (PSQ) is an Australian dental services company that operates a network of dental practices across the country. The company is focused on providing high-quality dental care through its branded clinics, which offer a range of services including general dentistry, cosmetic dentistry, orthodontics, and dental implants. With a commitment to patient-centered care, PSQ aims to enhance the dental experience by integrating modern technology and skilled professionals into its service delivery.
How the Company Makes MoneyPacific Smiles Group generates revenue primarily through the provision of dental services at its clinics. The company charges patients for various dental procedures, which range from routine check-ups to specialized treatments. Key revenue streams include payments from private patients, insurance reimbursements, and government healthcare programs. Additionally, PSQ may benefit from strategic partnerships with dental suppliers and equipment manufacturers, which can enhance operational efficiencies and potentially provide additional income through collaborative marketing efforts. The company also focuses on expanding its practice network, which can drive growth in patient volume and overall revenue.

Pacific Smiles Group Ltd Financial Statement Overview

Summary
Pacific Smiles Group Ltd exhibits positive revenue growth and strong cash flow generation, but faces challenges in profitability and high leverage. The company needs to focus on improving profit margins and reducing debt levels to enhance financial stability. While the cash flow position is robust, the balance sheet requires attention to ensure long-term sustainability.
Income Statement
65
Positive
Pacific Smiles Group Ltd has shown consistent revenue growth over the years, with a 2.54% increase in the latest period. However, the company's profitability margins, such as the net profit margin (1.02%) and EBIT margin (1.98%), are relatively low, indicating challenges in converting revenue into profit. The gross profit margin is strong at 88.19%, suggesting efficient cost management at the gross level. Overall, while revenue growth is positive, profitability remains a concern.
Balance Sheet
58
Neutral
The company's debt-to-equity ratio of 1.10 indicates a high level of leverage, which could pose financial risks if not managed properly. The equity ratio is relatively low, suggesting a reliance on debt financing. Return on equity has improved from negative to positive, but remains modest. The balance sheet reflects a need for improved financial stability and reduced leverage.
Cash Flow
72
Positive
Pacific Smiles Group Ltd has demonstrated strong free cash flow growth of 30.74%, indicating improved cash generation capabilities. The operating cash flow to net income ratio is 0.64, showing that operating cash flow adequately covers net income. The free cash flow to net income ratio is 0.80, highlighting effective cash conversion. Overall, the cash flow position is strong, with positive growth and adequate coverage ratios.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue196.03M193.65M177.91M165.32M139.47M153.18M
Gross Profit73.72M170.78M85.74M32.91M21.39M34.99M
EBITDA35.70M32.31M41.48M38.68M23.64M44.79M
Net Income1.97M1.97M8.04M2.42M-4.53M12.95M
Balance Sheet
Total Assets163.53M163.53M171.98M188.11M190.63M161.27M
Cash, Cash Equivalents and Short-Term Investments21.42M21.42M17.66M18.57M11.80M10.95M
Total Debt65.70M65.70M75.33M93.00M105.88M70.38M
Total Liabilities104.03M104.03M111.42M126.84M132.11M100.09M
Stockholders Equity59.50M59.50M60.56M61.27M58.51M61.18M
Cash Flow
Free Cash Flow23.03M23.03M28.97M29.80M-5.48M13.34M
Operating Cash Flow28.76M28.76M32.81M40.87M17.90M38.93M
Investing Cash Flow-5.33M-5.33M-3.36M-10.55M-22.13M-25.18M
Financing Cash Flow-19.67M-19.67M-30.36M-23.56M5.09M-18.08M

Pacific Smiles Group Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2.18
Price Trends
50DMA
1.74
Positive
100DMA
1.69
Positive
200DMA
1.79
Positive
Market Momentum
MACD
0.15
Negative
RSI
90.68
Negative
STOCH
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:PSQ, the sentiment is Positive. The current price of 2.18 is above the 20-day moving average (MA) of 1.97, above the 50-day MA of 1.74, and above the 200-day MA of 1.79, indicating a bullish trend. The MACD of 0.15 indicates Negative momentum. The RSI at 90.68 is Negative, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:PSQ.

Pacific Smiles Group Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AU$280.54M11.2110.25%7.34%6.65%
AU$352.32M178.693.28%9.05%-75.79%
AU$127.58M79.171.89%10.06%
AU$605.87M-27.89%67.26%
$7.86B-0.30-43.30%2.27%22.53%-2.21%
AU$170.03M-16.13-70.55%-257.32%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:PSQ
Pacific Smiles Group Ltd
2.18
0.27
14.14%
AU:RAC
Race Oncology Ltd.
3.50
2.06
143.06%
AU:ALC
Alcidion Group Limited
0.10
0.05
100.00%
AU:EMV
EMvision Medical Devices Ltd.
1.77
-0.19
-9.69%
AU:MVF
Monash IVF Group Ltd
0.70
-0.45
-39.13%

Pacific Smiles Group Ltd Corporate Events

Beam Dental Initiates Full Acquisition of Pacific Smiles Group
Oct 24, 2025

Beam Dental Bidco Pty Ltd has initiated a compulsory acquisition process to acquire all remaining shares of Pacific Smiles Group Ltd, having already secured over 90% of the shares. This move marks a significant step in Beam Dental’s strategy to consolidate its control over Pacific Smiles, potentially impacting the company’s operations and market positioning.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Beam Dental Bidco Launches Takeover Bid for Pacific Smiles Group
Oct 21, 2025

Beam Dental Bidco Pty Ltd has announced an off-market takeover bid for all ordinary shares of Pacific Smiles Group Ltd that it does not already own. This move, detailed in a supplementary bidder’s statement lodged with the Australian Securities and Investments Commission, could significantly impact Pacific Smiles’ operations and market positioning, potentially altering stakeholder interests.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Pacific Smiles Group Ltd Faces Takeover Bid by Beam Dental Bidco
Oct 15, 2025

Pacific Smiles Group Ltd has announced that Beam Dental Bidco Pty Ltd is making an unconditional all-cash off-market takeover bid to acquire all shares it does not already own in the company at $2.20 per share. The Independent Board Committee of Pacific Smiles has recommended shareholders accept the offer, deeming it fair and reasonable in the absence of a superior proposal, as supported by an Independent Expert’s Report.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Beam Dental Completes Dispatch for Pacific Smiles Takeover Bid
Oct 15, 2025

Beam Dental Bidco Pty Ltd has completed the dispatch of its Bidder’s Statement for an off-market takeover bid to acquire all ordinary shares of Pacific Smiles Group Ltd that it does not already own. This move signifies a strategic effort by Beam Dental to consolidate its position in the dental services market, potentially impacting stakeholders by altering the ownership structure and operational strategies of Pacific Smiles.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$2.50 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Beam Dental Bidco Launches Takeover Bid for Pacific Smiles Group
Oct 9, 2025

Pacific Smiles Group Ltd, a company listed on the ASX under the ticker PSQ, is the subject of an off-market takeover bid by Beam Dental Bidco Pty Ltd, which aims to acquire all ordinary shares it does not already own. The Bidder’s Statement for this takeover was lodged with the Australian Securities and Investments Commission and is set to be dispatched to shareholders along with Pacific Smiles’ Target’s Statement. This move could significantly impact Pacific Smiles’ market position and shareholder dynamics.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Leadership Transition at Pacific Smiles Group: New CEO Appointed
Oct 2, 2025

Pacific Smiles Group Ltd announced the resignation of its Managing Director and CEO, Gary Carroll, effective 31 October 2025, acknowledging his leadership during a transformative period for the company. Michelle Dries has been appointed as the new CEO, effective 20 October 2025, bringing extensive experience in healthcare and consumer businesses, which is expected to drive further growth and operational excellence.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Pacific Smiles Group Schedules 2025 Annual General Meeting
Sep 30, 2025

Pacific Smiles Group Ltd has announced the scheduling of its Annual General Meeting (AGM) for October 31, 2025, in Sydney, Australia. Shareholders are encouraged to participate either in person or by proxy, with the company emphasizing the importance of shareholder votes on the resolutions to be discussed. The meeting will include a poll for decision-making, and shareholders are urged to submit questions in advance.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Pacific Smiles Group Reports Strong FY25 Financial Growth
Aug 13, 2025

Pacific Smiles Group Ltd reported strong financial results for the fiscal year ending June 30, 2025, with an 8.7% increase in patient fees and a 12.1% rise in underlying EBITDA. The company attributes its growth to strategic investments in operational efficiencies and increased patient appointments, which have bolstered profitability and cash reserves, despite the closure of two centers.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$1.95 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Pacific Smiles Group Ltd Strengthens Corporate Governance Framework
Aug 13, 2025

Pacific Smiles Group Ltd has reaffirmed its commitment to high standards of corporate governance by outlining its compliance with the ASX Corporate Governance Principles. The company has established various committees, including a Nomination and Remuneration Committee and an Audit and Risk Management Committee, to ensure effective management and oversight. These measures are designed to align the interests of senior management with stakeholders and maintain open communication with auditors, thereby enhancing the company’s governance culture and operational success.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$1.95 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Pacific Smiles Reports Revenue Growth Amid Profit Decline
Aug 13, 2025

Pacific Smiles Group Ltd reported a 9.1% increase in revenue for the year ending June 2025, reaching $196.023 million. However, the company’s statutory profit after tax fell significantly by 75.5% to $1.971 million, primarily due to one-time expenses related to severance, executive incentives, and costs associated with a takeover bid by Genesis Capital Manager I Pty Ltd. Despite these challenges, the underlying profit showed a 38.6% increase, indicating strong operational performance. The company did not declare any dividends for the year, reflecting a strategic focus on reinvestment and managing financial obligations.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$1.95 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Pacific Smiles Completes Minimum Holding Buy-Back to Optimize Capital Structure
Aug 8, 2025

Pacific Smiles Group Ltd has successfully completed a minimum holding buy-back of unmarketable parcels of shares, acquiring and cancelling 8,527 shares valued at $14,398.80. This move is expected to reduce administrative costs and streamline the company’s capital structure, decreasing the number of shareholders from 349 to 252.

The most recent analyst rating on (AU:PSQ) stock is a Hold with a A$1.95 price target. To see the full list of analyst forecasts on Pacific Smiles Group Ltd stock, see the AU:PSQ Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 14, 2025